184 related articles for article (PubMed ID: 11375906)
1. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat.
Wong YC; Wang YZ; Lee JS; Tam NN; Lee D
Tumour Biol; 2000; 21(6):328-36. PubMed ID: 11006573
[TBL] [Abstract][Full Text] [Related]
3. Over expression of ID-1 in prostate cancer.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
J Urol; 2002 Jun; 167(6):2598-602. PubMed ID: 11992094
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780.
Thompson CJ; Tam NN; Joyce JM; Leav I; Ho SM
Endocrinology; 2002 Jun; 143(6):2093-105. PubMed ID: 12021174
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.
Ho SM; Leav I; Ghatak S; Merk F; Jagannathan VS; Mallery K
Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
[TBL] [Abstract][Full Text] [Related]
8. The prostate gland and prostate carcinogenesis.
Wong YC; Wang YZ; Tam NN
Ital J Anat Embryol; 1998; 103(4 Suppl 1):237-52. PubMed ID: 11315954
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.
Wang YZ; Wong YC
Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085
[TBL] [Abstract][Full Text] [Related]
10. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
11. Estrogen enhancement of androgen-responsive gene expression in hormone-induced hyperplasia in the ventral prostate of F344 rats.
Fujimoto N; Suzuki T; Honda H; Kitamura S
Cancer Sci; 2004 Sep; 95(9):711-5. PubMed ID: 15471555
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
13. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
Li H; Gerald WL; Benezra R
Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
[TBL] [Abstract][Full Text] [Related]
15. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
Han X; Liehr JG; Bosland MC
Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.
Chetcuti A; Margan S; Mann S; Russell P; Handelsman D; Rogers J; Dong Q
Prostate; 2001 May; 47(2):132-40. PubMed ID: 11340636
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids.
Li SC; Chen GF; Chan PS; Choi HL; Ho SM; Chan FL
Prostate; 2001 Sep; 49(1):58-71. PubMed ID: 11550211
[TBL] [Abstract][Full Text] [Related]
18. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy.
July LV; Akbari M; Zellweger T; Jones EC; Goldenberg SL; Gleave ME
Prostate; 2002 Feb; 50(3):179-88. PubMed ID: 11813210
[TBL] [Abstract][Full Text] [Related]
19. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 Jan; 60(1):170-6. PubMed ID: 10646870
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
